Therapeutic Areas : Neuroscience, -Multiple Sclerosis

With rapidly changing guidelines and treatment indications, it can be difficult discerning when to start a disease-modifying therapy in the early spectrum of multiple sclerosis (MS), such as clinically and radiologically isolated syndrome; how to discuss MS management in women of childbearing age; or how to use the new guidelines to confirm an MS diagnosis. In this supplement, these topics will be addressed along with recognizing treatment failure, knowing when to switch therapies, and how to incorporate patient preference in treatment-related decisions.